CLINICAL_TRIALS
trial_result
· 2017-03-08
Clinical Trial Update: Study of Arsenic Trioxide in Small Cell Lung Cancer [Phase 2]
Summary
Phase 2 trial of arsenic trioxide for small cell lung cancer has completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Lung Cancer, Cancer of Lung | Phase 2 | Status: COMPLETED | Results posted: 2017-03-08